- Investing Ideas
- South Korean Pharmaceuticals & Biotech Leverage Leaders
South Korean Pharmaceuticals & Biotech Leverage Leaders
Results
16
16 companies
Hanall Biopharma
Market Cap: ₩3.1t
A pharmaceutical company, manufactures and sells pharmaceutical products in South Korea and internationally.
A009420
₩61,100.00
7D
12.1%
1Y
59.5%
D&D Pharmatech
Market Cap: ₩3.8t
Engages in the research and development and manufacturing of pharmaceuticals in South Korea.
A347850
₩86,500.00
7D
3.6%
1Y
525.7%
Hanmi Pharm
Market Cap: ₩7.8t
A biopharmaceutical company, engages in the manufacture and sale of pharmaceutical products in South Korea, China, Japan, the United States, and internationally.
A128940
₩616,000.00
7D
2.5%
1Y
129.4%
Peptron
Market Cap: ₩6.3t
Engages in the development of peptide-based medicines.
A087010
₩272,000.00
7D
11.5%
1Y
209.1%
SK Biopharmaceuticals
Market Cap: ₩9.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩117,200.00
7D
7.3%
1Y
1.7%
ALTEOGEN
Market Cap: ₩21.7t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩406,000.00
7D
6.3%
1Y
6.0%
Caregen
Market Cap: ₩7.1t
A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.
A214370
₩145,400.00
7D
20.4%
1Y
433.6%
Samsung BiologicsLtd
Market Cap: ₩79.5t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,717,000.00
7D
0.4%
1Y
-3.0%
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩355,500.00
7D
3.0%
1Y
25.6%
ABL Bio
Market Cap: ₩10.5t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩189,500.00
7D
2.8%
1Y
400.0%
Aimed Bio
Market Cap: ₩3.3t
Develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases.
A0009K0
₩51,700.00
7D
-0.2%
1Y
n/a
Celltrion
Market Cap: ₩53.2t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩243,000.00
7D
2.1%
1Y
42.0%
ST PharmLtd
Market Cap: ₩3.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩151,100.00
7D
3.0%
1Y
85.4%
LigaChem Biosciences
Market Cap: ₩6.6t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩180,400.00
7D
2.2%
1Y
60.5%
Voronoi
Market Cap: ₩5.1t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩281,000.00
7D
32.2%
1Y
164.1%
Yuhan
Market Cap: ₩8.4t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩113,200.00
7D
4.0%
1Y
-6.1%